Found 8 results
Author Title [ Type(Desc)] Year
Filters: Author is Dally, Len  [Clear All Filters]
Journal Article
S. Joseph, Quinn, K., Greenwood, A., Cope, A. V., McKay, P. F., Hayes, P. J., Kopycinski, J. T., Gilmour, J., Miller, A. N., Geldmacher, C., Nadai, Y., Ahmed, M. I. M., Montefiori, D. C., Dally, L., Bouliotis, G., Lewis, D. J. M., Tatoud, R., Wagner, R., Esteban, M., Shattock, R. J., McCormack, S., and Weber, J., A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes, Front Immunol, vol. 8, p. 149, 2017.
T. Ford, Wenden, C., Mbekeani, A., Dally, L., Cox, J. H., Morin, M., Winstone, N., Hill, A. V. S., Gilmour, J., and Ewer, K. J., Cryopreservation-Related Loss of Antigen-Specific IFNγ Producing CD4(+) T-cells Can Skew Immunogenicity Data in Vaccine Trials: Lessons from a Malaria Vaccine Trial Substudy, Vaccine, vol. 35, no. 15, pp. 1898-1906, 2017.
S. Chakraborty, Harro, C., DeNearing, B., Bream, J., Bauers, N., Dally, L., Flores, J., Van de Verg, L., Sack, D. A., and Walker, R., Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects., Clin Vaccine Immunol, vol. 23, no. 4, pp. 315-325, 2016.
J. Nyombayire, Anzala, O., Gazzard, B., Karita, E., Bergin, P., Hayes, P., Kopycinski, J., Omosa-Manyonyi, G., Jackson, A., Bizimana, J., Farah, B., Sayeed, E., Parks, C. L., Inoue, M., Hironaka, T., Hara, H., Shu, T., Matano, T., Dally, L., Barin, B., Park, H., Gilmour, J., Lombardo, A., Excler, J. - L., Fast, P., Laufer, D. S., and Cox, J. H., First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens, J Infect Dis, vol. 215, no. 1, pp. 95-104, 2017.
S. Chakraborty, Harro, C., DeNearing, B., Brubaker, J., Connor, S., Maier, N., Dally, L., Flores, J., A Bourgeois, L., Walker, R., and Sack, D. A., Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers., PLoS Negl Trop Dis, vol. 12, no. 4, p. e0006442, 2018.
S. Kratochvil, McKay, P. F., Kopycinski, J. T., Bishop, C., Hayes, P. John, Muir, L., Pinder, C. L., Cizmeci, D., King, D., Aldon, Y., Wines, B. D., P. Hogarth, M., Chung, A. W., Kent, S. J., Held, K., Geldmacher, C., Dally, L., Santos, N. S., Cole, T., Gilmour, J., Fidler, S., and Shattock, R. J., A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens, Front Immunol, vol. 8, no. 595, 2017.
M. J. Groome, Koen, A., Fix, A., Page, N., Jose, L., Madhi, S. A., McNeal, M., Dally, L., Cho, I., Power, M., Flores, J., and Cryz, S., Safety and Immunogenicity of a Parenteral P2-VP8-P[8] Subunit Rotavirus Vaccine in Toddlers and Infants in South Africa: A Randomised, Double-Blind, Placebo-Controlled Trial, Lancet Infect Dis, vol. 17, no. 8, pp. 843-853, 2017.
A. D. Fix, Harro, C., McNeal, M., Dally, L., Flores, J., Robertson, G., Boslego, J. W., and Cryz, S., Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults., Vaccine, vol. 33, no. 31, pp. 3766-3772, 2015.